Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
WELL Health Technologies Corp. (WELL.TO)
Vancouver, BC, CA
WELL Health Technologies Corp. is a leading digital healthcare company with operations in Canada, the United States, and internationally, primarily supporting medical professionals. The company delivers a full spectrum of patient services through various channels. These encompass general primary care; rehabilitative therapies such as physiotherapy, occupational therapy, and chiropractic services; dietary and mental health counselling; and sleep-related treatments. Furthermore, they provide specialized medical attention from gastroenterologists, a wide array of diagnostic services including cardiology, women's health, bone/muscle health, and cancer screening, alongside comprehensive telehealth options. Beyond direct patient care, WELL Health equips practitioners with a suite of technological solutions. This portfolio includes the OSCAR Pro electronic medical record (EMR) system, several virtual health platforms like Tia Health and Circle Medical, and Apps.health, a dedicated marketplace for digital health applications. They also offer Insig for virtual care and patient engagement, revenue cycle management solutions encompassing outsourced billing, and advanced cybersecurity with patient data privacy safeguards. As of December 31, 2021, the company operated 30 primary and executive care clinics, and provided core, specialized, and accredited diagnostic health services from 49 locations throughout Ontario. Established in 2010, the company was initially known as Wellness Lifestyles Inc. before adopting its current name in July 2018. WELL Health Technologies Corp. is headquartered in Vancouver, Canada.
Based on only 1 article — low confidence
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.25% | -6.21% | +8.22% | +4.08% | -1.92% | +2.26% | +0.25% | -19.05% | -41.29% | +2,620.00% | +2,814.29% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 5 | 0 |
| Buy | 7 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+52.3% ★ Q1'26: +25.2% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-122.4% Q1'26: +74.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+6.2% Q1'26: +1.3% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+8.1% Q1'26: +5.4% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+5.9% Q1'26: +3.6% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+577.6% Q1'26: +1.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×3.44× Q1'26: 4.36× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 11 Rev. Ana. 7 EPS Ana. |
Dec 2027 12 Rev. Ana. 6 EPS Ana. |
Dec 2028 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.90M
est: 10.01M (-41.1%)
|
32.81M
est: 32.01M (+2.5%)
|
50.24M
est: 50.18M (+0.1%)
|
302.32M
est: 299.54M (+0.9%)
|
569.14M
est: 566.09M (+0.5%)
|
776.05M
est: 910.42M (-14.8%)
|
919.69M
est: 989.98M (-7.1%)
|
1.40B
est: 1.40B (0.0%)
|
1.56B
1.55B – 1.60B
+11.6% YoY
|
1.67B
1.60B – 1.74B
+6.8% YoY
|
1.76B
1.75B – 1.76B
+5.2% YoY
|
| EBITDA |
-2.18M
est: 984.6K (-321.7%)
|
-4.16M
est: 3.15M (-232.0%)
|
-495.0K
est: 4.94M (-110.0%)
|
21.27M
est: 29.48M (-27.8%)
|
95.07M
est: 55.71M (+70.7%)
|
101.88M
est: 118.28M (-13.9%)
|
122.52M
est: 128.61M (-4.7%)
|
206.79M
est: 181.94M (+13.7%)
|
203.02M
201.08M – 207.51M
+11.6% YoY
|
216.90M
207.28M – 226.68M
+6.8% YoY
|
228.21M
227.55M – 228.87M
+5.2% YoY
|
| EBIT |
-2.01M
est: 37.4K (-5,492.8%)
|
-6.31M
est: 119.5K (-5,380.7%)
|
-5.23M
est: 187.4K (-2,891.2%)
|
-17.44M
est: 1.12M (-1,659.2%)
|
39.87M
est: 2.11M (+1,785.7%)
|
41.11M
est: 36.54M (+12.5%)
|
50.21M
est: 39.73M (+26.4%)
|
113.03M
est: 56.20M (+101.1%)
|
62.71M
62.11M – 64.10M
+11.6% YoY
|
67.00M
64.03M – 70.02M
+6.8% YoY
|
70.49M
70.29M – 70.70M
+5.2% YoY
|
| Net Income |
-2.04M
est: -7.64M (+73.2%)
|
-7.79M
est: -21.65M (+64.0%)
|
-2.62M
est: -20.88M (+87.4%)
|
-30.69M
est: -49.94M (+38.6%)
|
19.07M
est: 61.77M (-69.1%)
|
82.0K
est: 1.05B (-100.0%)
|
32.61M
est: 415.25M (-92.1%)
|
-50.21M
est: 725.45M (-106.9%)
|
448.60M
258.81M – 638.40M
-38.2% YoY
|
468.03M
222.11M – 713.95M
+4.3% YoY
|
433.16M
415.92M – 450.40M
-7.5% YoY
|
| SGA |
3.78M
est: 4.11M (-7.9%)
|
14.92M
est: 13.14M (+13.5%)
|
27.35M
est: 20.61M (+32.7%)
|
123.52M
est: 123.00M (+0.4%)
|
224.11M
est: 232.46M (-3.6%)
|
276.98M
est: 330.95M (-16.3%)
|
321.47M
est: 359.88M (-10.7%)
|
432.38M
est: 509.09M (-15.1%)
|
568.07M
562.65M – 580.65M
+11.6% YoY
|
606.91M
580.00M – 634.27M
+6.8% YoY
|
638.56M
636.70M – 640.41M
+5.2% YoY
|
| EPS |
-0.03
est: -0.03 (-2.3%)
|
-0.08
est: -0.09 (+5.4%)
|
-0.02
est: -0.08 (+76.1%)
|
-0.16
est: -0.20 (+18.4%)
|
0.09
est: 0.24 (-63.6%)
|
0.00
est: 0.61 (-100.0%)
|
0.13
est: 0.24 (-45.8%)
|
-0.03
est: 0.41 (-107.4%)
|
0.27
0.15 – 0.37
-33.6% YoY
|
0.33
0.13 – 0.41
+22.6% YoY
|
0.25
0.24 – 0.26
-24.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares S&P/TSX SmallCap Index ETF XCS.TO | 0.28% | 486.3K | 0.60% |
| 2 | Goldman Sachs Innovate Equity ETF GINN | 0.11% | 240.6K | 0.50% |
| 3 | State Street SPDR S&P International Small Cap ETF GWX | 0.06% | 498.1K | 0.40% |
| 4 | iShares ESG Advanced MSCI Canada Index ETF XCSR.TO | 0.03% | 120.2K | 0.17% |
| 5 | Dimensional - International Small Cap ETF DFIS | 0.03% | 1.72M | 0.39% |
| 6 | Dimensional - International Small Cap Value ETF DISV | 0.03% | 1.39M | 0.42% |
| 7 | UBS MSCI World Small Cap Socially Responsible UCITS ETF USD dis WSCR.L | 0.02% | 194.7K | 0.23% |
| 8 | UBS MSCI World Small Cap Socially Responsible UCITS ETF USD acc WSCSRI.SW | 0.02% | 194.8K | 0.23% |
| 9 | TD Canadian Equity Index ETF TTP.TO | 0.02% | 890.3K | 0.05% |
| 10 | Dimensional - International Vector Equity ETF DXIV | 0.01% | 23.3K | 0.53% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| James T. Kreger | Chief Executive Officer of WELL Health USA & CRH Medical | 864.5K | male |
| Dina Sergi | Chief Executive Officer of MyHealth Partners Inc. | 644.4K | female |
| Hamed Shahbazi | Founder, Chairman & Chief Executive Officer | 500.0K | male |
| Amir Javidan | Chief Operating Officer | 265.0K | male |
| Eva Fong | Chief Financial Officer | 265.0K | female |
| Brian Eric Levinkind | Senior Vice President of Corporate Development | 216.0K | male |
| Chris Ericksen | Senior Vice President of Strategic Partnerships & Marketing | — | male |
| Pardeep S. Sangha | Vice President of Corporate Strategy & Investor Relations | — | male |
| Ric Leong | Chief Accounting Officer | — | male |
| Shane Joseph Sabatino | Chief People Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for WELL.TO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
